These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 28930292)

  • 1. Proton-pump inhibitors: understanding the complications and risks.
    Malfertheiner P; Kandulski A; Venerito M
    Nat Rev Gastroenterol Hepatol; 2017 Dec; 14(12):697-710. PubMed ID: 28930292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
    Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
    Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
    Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
    Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition.
    Fossmark R; Jianu CS; Martinsen TC; Qvigstad G; Syversen U; Waldum HL
    Scand J Gastroenterol; 2008 Jan; 43(1):20-4. PubMed ID: 18938772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative risk factors associated with the development of fundic gland polyps.
    Huang CZ; Lai RX; Mai L; Zhou HL; Chen HJ; Guo HX
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1217-21. PubMed ID: 25187299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors.
    Kumar KR; Iqbal R; Coss E; Park C; Cryer B; Genta RM
    Hum Pathol; 2013 Dec; 44(12):2706-10. PubMed ID: 24071014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
    Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
    Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological characteristics of gastric polyps and the relationship between fundic gland polyps, Helicobacter pylori infection, and proton pump inhibitors.
    Gao W; Huang Y; Lu S; Li C
    Ann Palliat Med; 2021 Feb; 10(2):2108-2114. PubMed ID: 33725768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of the long-term use of proton pump inhibitors.
    Thomson AB; Sauve MD; Kassam N; Kamitakahara H
    World J Gastroenterol; 2010 May; 16(19):2323-30. PubMed ID: 20480516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
    Nasser SC; Slim M; Nassif JG; Nasser SM
    World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach.
    Takahari K; Haruma K; Ohtani H; Kiyoto S; Watanabe A; Kamada T; Manabe N; Hatano Y
    Intern Med; 2017 Oct; 56(20):2699-2703. PubMed ID: 28924108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors.
    Minalyan A; Gabrielyan L; Scott D; Jacobs J; Pisegna JR
    Curr Gastroenterol Rep; 2017 Aug; 19(8):42. PubMed ID: 28733944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
    Laine L; Ahnen D; McClain C; Solcia E; Walsh JH
    Aliment Pharmacol Ther; 2000 Jun; 14(6):651-68. PubMed ID: 10848649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
    Lamberts R
    Microsc Res Tech; 2000 Mar; 48(6):357-66. PubMed ID: 10738317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic fundic gland polyps are not associated with proton pump inhibitors therapy but negatively correlate with Helicobacter pylori infection in China.
    Cao H; Qu R; Zhang Z; Kong X; Wang S; Jiang K; Wang B
    Chin Med J (Engl); 2014; 127(7):1239-43. PubMed ID: 24709173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term proton pump inhibitor use and gastrointestinal cancer.
    Graham DY; Genta RM
    Curr Gastroenterol Rep; 2008 Dec; 10(6):543-7. PubMed ID: 19006608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Massive fundic gland polyposis caused by chronic proton pump inhibitor therapy].
    Hegedus I; Csizmadia C; Lomb Z; Cseke L; Enkh-Amar Y; Pajor L; Bogner B
    Orv Hetil; 2012 Mar; 153(9):351-6. PubMed ID: 22348851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors and gastric neoplasia.
    Kuipers EJ
    Gut; 2006 Sep; 55(9):1217-21. PubMed ID: 16905689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.
    Tran-Duy A; Spaetgens B; Hoes AW; de Wit NJ; Stehouwer CD
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1706-1719.e5. PubMed ID: 27211501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fundic gland polyps are not induced by proton pump inhibitor therapy.
    Vieth M; Stolte M
    Am J Clin Pathol; 2001 Nov; 116(5):716-20. PubMed ID: 11710689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.